Rigel Pharmaceuticals Inc.
VP, Clinical Development
Rigel Pharmaceuticals Inc., South San Francisco, California, us, 94083
Position Summary Reporting to the Chief Medical Officer (CMO), the Vice President of Clinical Development manages the clinical development of drug candidates, creating integrated strategies and plans tailored for registration and commercial success. The role requires a deep understanding of all phases of pharmaceutical drug development, regulatory expertise, and collaboration with key stakeholders such as Biometrics, Research, Medical Affairs, and Regulatory Affairs. The Vice President provides strategic and operational leadership to clinical project teams.
Salary Range Premium: $318,240 - $374,000
Ensure you read the information regarding this opportunity thoroughly before making an application. National: $286,500 – $337,000 Essential Duties and Responsibilities
Lead the development and execution of clinical program strategies, including clinical development plans. Design, plan, execute, interpret, and communicate clinical trials and research results in accordance with medical, scientific, regulatory, and quality standards, in collaboration with the CMO. Support the creation and updates of clinical trial protocols, Investigator’s Brochures, clinical study reports, statistical analysis plans, and regulatory documents with internal stakeholders. Establish and maintain relationships with external stakeholders such as academic leaders, KOLs, safety committees, patient advocacy groups, and manage advisory boards. Support business development activities, including due diligence and in-licensing. Oversee pharmacovigilance activities, monitor drug safety profiles, and ensure compliance with regulatory guidelines. Represent clinical development on project teams and serve as a member of the IST Review Committee. Assist with Medical Affairs scientific publications as needed. Coordinate with Clinical Operations and CROs to execute clinical programs, including medical monitoring, safety review, data review, and investigator meetings. Manage and forecast resources for clinical programs with support from the Head of Clinical Operations and Finance. Collaborate with Research, Regulatory Affairs, and Medical Affairs on lifecycle management, new studies, and compassionate use programs. Qualifications
M.D. degree with advanced knowledge in hematology/oncology; board certification preferred. At least 8 years of experience in clinical research or drug development, with a minimum of 6 years in the industry. Experience working with health authorities. Ability to evaluate, interpret, and present complex scientific data. Thorough knowledge of GCP, statistics, and trial design. Proven leadership and management skills with a track record of high-quality outputs. Experience working cross-functionally with multidisciplinary teams and external experts. Excellent verbal and written communication and presentation skills. Rigel Pharmaceuticals, Inc. is an equal opportunity employer, considering all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, genetic information, national origin, veteran status, disability, or other protected characteristics.
#J-18808-Ljbffr
Ensure you read the information regarding this opportunity thoroughly before making an application. National: $286,500 – $337,000 Essential Duties and Responsibilities
Lead the development and execution of clinical program strategies, including clinical development plans. Design, plan, execute, interpret, and communicate clinical trials and research results in accordance with medical, scientific, regulatory, and quality standards, in collaboration with the CMO. Support the creation and updates of clinical trial protocols, Investigator’s Brochures, clinical study reports, statistical analysis plans, and regulatory documents with internal stakeholders. Establish and maintain relationships with external stakeholders such as academic leaders, KOLs, safety committees, patient advocacy groups, and manage advisory boards. Support business development activities, including due diligence and in-licensing. Oversee pharmacovigilance activities, monitor drug safety profiles, and ensure compliance with regulatory guidelines. Represent clinical development on project teams and serve as a member of the IST Review Committee. Assist with Medical Affairs scientific publications as needed. Coordinate with Clinical Operations and CROs to execute clinical programs, including medical monitoring, safety review, data review, and investigator meetings. Manage and forecast resources for clinical programs with support from the Head of Clinical Operations and Finance. Collaborate with Research, Regulatory Affairs, and Medical Affairs on lifecycle management, new studies, and compassionate use programs. Qualifications
M.D. degree with advanced knowledge in hematology/oncology; board certification preferred. At least 8 years of experience in clinical research or drug development, with a minimum of 6 years in the industry. Experience working with health authorities. Ability to evaluate, interpret, and present complex scientific data. Thorough knowledge of GCP, statistics, and trial design. Proven leadership and management skills with a track record of high-quality outputs. Experience working cross-functionally with multidisciplinary teams and external experts. Excellent verbal and written communication and presentation skills. Rigel Pharmaceuticals, Inc. is an equal opportunity employer, considering all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, genetic information, national origin, veteran status, disability, or other protected characteristics.
#J-18808-Ljbffr